SI9300469A - Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof - Google Patents

Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof Download PDF

Info

Publication number
SI9300469A
SI9300469A SI9300469A SI9300469A SI9300469A SI 9300469 A SI9300469 A SI 9300469A SI 9300469 A SI9300469 A SI 9300469A SI 9300469 A SI9300469 A SI 9300469A SI 9300469 A SI9300469 A SI 9300469A
Authority
SI
Slovenia
Prior art keywords
acyclovir
cream
water
ester
salt
Prior art date
Application number
SI9300469A
Other languages
English (en)
Slovenian (sl)
Inventor
Knud Erik Gebhard-Hansen
Soren Bols Pedersen
Karen Bjornsdottir
Bodil Gyllembourg Lissau
Borge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of SI9300469A publication Critical patent/SI9300469A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI9300469A 1992-09-09 1993-09-09 Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof SI9300469A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf

Publications (1)

Publication Number Publication Date
SI9300469A true SI9300469A (en) 1994-03-31

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300469A SI9300469A (en) 1992-09-09 1993-09-09 Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof

Country Status (27)

Country Link
EP (1) EP0662819B1 (no)
JP (1) JPH08501089A (no)
AT (1) ATE137113T1 (no)
AU (1) AU4945393A (no)
BG (1) BG62032B1 (no)
BR (1) BR9307024A (no)
CA (1) CA2142493A1 (no)
CZ (1) CZ284007B6 (no)
DE (1) DE69302396T2 (no)
DK (1) DK169121B1 (no)
EE (1) EE03088B1 (no)
ES (1) ES2086235T3 (no)
FI (1) FI112777B (no)
GR (1) GR3019984T3 (no)
HR (1) HRP931160B1 (no)
HU (1) HUT72606A (no)
LT (1) LT3056B (no)
LV (1) LV10912B (no)
NO (1) NO308234B1 (no)
PL (1) PL172663B1 (no)
RO (1) RO113306B1 (no)
RU (1) RU2128503C1 (no)
SI (1) SI9300469A (no)
SK (1) SK280119B6 (no)
UA (1) UA41897C2 (no)
WO (1) WO1994005258A1 (no)
ZA (1) ZA936661B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
ES2429443T3 (es) * 2004-04-19 2013-11-14 Strategic Science & Technologies, Llc Suministro transdérmico de sustancias beneficiosas efectuado mediante un entorno de fuerza iónica elevada
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US20120142623A1 (en) * 2006-07-07 2012-06-07 Michael Lagunoff Compositions And Methods For Predicting Inhibitors Of Protein Targets
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
EP0662819B1 (en) 1996-04-24
HRP931160A2 (en) 1995-12-31
NO308234B1 (no) 2000-08-21
LT3056B (en) 1994-10-25
UA41897C2 (uk) 2001-10-15
ES2086235T3 (es) 1996-06-16
HRP931160B1 (en) 1999-04-30
LV10912A (lv) 1995-12-20
RU2128503C1 (ru) 1999-04-10
FI951086A0 (fi) 1995-03-08
DE69302396T2 (de) 1996-08-14
SK280119B6 (sk) 1999-08-06
DK111392D0 (da) 1992-09-09
BR9307024A (pt) 1999-06-29
CZ284007B6 (cs) 1998-07-15
BG62032B1 (bg) 1999-01-29
GR3019984T3 (en) 1996-08-31
CZ59995A3 (en) 1995-09-13
CA2142493A1 (en) 1994-03-17
WO1994005258A1 (en) 1994-03-17
PL172663B1 (pl) 1997-10-31
LV10912B (en) 1996-08-20
JPH08501089A (ja) 1996-02-06
FI951086A (fi) 1995-03-08
EP0662819A1 (en) 1995-07-19
BG99484A (bg) 1995-12-29
HUT72606A (en) 1996-05-28
HU9500702D0 (en) 1995-04-28
ZA936661B (en) 1994-05-20
LTIP959A (en) 1994-05-15
PL307860A1 (en) 1995-06-26
EE03088B1 (et) 1998-06-15
DK169121B1 (da) 1994-08-22
NO950895D0 (no) 1995-03-08
ATE137113T1 (de) 1996-05-15
NO950895L (no) 1995-03-08
SK29195A3 (en) 1997-01-08
DE69302396D1 (de) 1996-05-30
RU95110930A (ru) 1997-03-27
FI112777B (fi) 2004-01-15
DK111392A (da) 1994-03-10
AU4945393A (en) 1994-03-29
RO113306B1 (ro) 1998-06-30

Similar Documents

Publication Publication Date Title
JP4230109B2 (ja) 両性界面活性剤、アルコキシル化セチルアルコールおよび極性薬剤を含む医薬組成物
KR100867246B1 (ko) 모발 성장 촉진용 제제
SI9300469A (en) Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof
KR960001373B1 (ko) 제약학적 활성 물질의 침투 증강용 2성분계 침투증강 조성물
DE3212053A1 (de) Kutanapplizierbare pharmazeutische zusammensetzungen
JP3487633B2 (ja) 皮膚疾患治療乳剤
EP0641221A1 (en) Anhydrous formulations for administering lipophilic agents
US4263313A (en) Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
JP2555555B2 (ja) 抗真菌性外用製剤
US20020127249A1 (en) Novel formulation for use in pain management
JPWO2020022368A1 (ja) 液状外用剤
KR100707329B1 (ko) 디메티콘을 함유하는 아시클로비르 조성물
JP3333428B2 (ja) 皮膚外用剤
EP1879565A2 (en) Topical pharmaceutical formulation containing nimesulide
JPH0121131B2 (no)
JPH05170640A (ja) 皮膚外用剤
JPH05310552A (ja) 皮膚外用剤